-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
ZyVersa Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q4 2022 to Q1 2024.
- ZyVersa Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $8.66K, a 64.3% decline year-over-year.
- ZyVersa Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $100K, a 1991% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)